---
document_datetime: 2024-08-12 16:39:38
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/fasturtec-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: fasturtec-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 10.2903635
conversion_datetime: 2025-12-20 12:32:45.797143
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Fasturtec

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0070              | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 13/05/2024                          |                                             | Annex II                         |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| II/0069            | B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product                                                                                                                                                                              | 22/02/2024   | n/a        |                  |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------|-----------------------------------|
| IB/0068/G          | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                        | 30/10/2023   | n/a        |                  |                                   |
| PSUSA/2613/ 202302 | Periodic Safety Update EU Single assessment - rasburicase                                                                                                                                                                                                                                                                                                                                                              | 28/09/2023   | n/a        |                  | PRAC Recommendation - maintenance |
| N/0067             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                       | 26/06/2023   | 07/12/2023 | Labelling and PL |                                   |
| II/0064/G          | This was an application for a group of variations. B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product | 08/12/2022   | 07/12/2023 | SmPC and PL      |                                   |

<div style=\"page-break-after: always\"></div>

|           | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 28/10/2022   | 18/11/2022   | SmPC, Labelling and PL   | T/0065                 |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|------------------------|
| II/0063/G | This was an application for a group of variations. B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 28/04/2022   | n/a          |                          | changes to an approved |
| IB/0061   | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                            | 19/11/2021   | n/a          |                          |                        |
| N/0062    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 09/11/2021   | 18/11/2022   | PL                       |                        |
| IAIN/0060 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 20/11/2020   | 15/11/2021   | Annex II and PL          |                        |

<div style=\"page-break-after: always\"></div>

|                    | responsible for batch release                                                                                                                                                                                                                                                                                                      |            |            |                       |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-----------------------------------|
| WS/1829            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                       | 12/11/2020 | 15/11/2021 | SmPC, Annex II and PL |                                   |
| PSUSA/2613/ 202002 | Periodic Safety Update EU Single assessment - rasburicase                                                                                                                                                                                                                                                                          | 01/10/2020 | n/a        |                       | PRAC Recommendation - maintenance |
| N/0057             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                   | 21/02/2020 | 15/11/2021 | PL                    |                                   |
| IB/0056            | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                   | 29/01/2020 | n/a        |                       |                                   |
| IB/0055/G          | This was an application for a group of variations. B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB | 25/10/2019 | n/a        |                       |                                   |
| N/0054             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                   | 23/11/2017 | 15/11/2021 | Labelling and PL      |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/2613/ 201702   | Periodic Safety Update EU Single assessment - rasburicase                                                                                                                                                                                                                                                                                                                                                                                                                   | 28/09/2017   | n/a        |                 | PRAC Recommendation - maintenance   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-------------------------------------|
| IAIN/0052/G          | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                   | 17/01/2017   | 24/05/2017 | Annex II and PL |                                     |
| IA/0051              | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                              | 07/10/2016   | n/a        |                 |                                     |
| II/0049              | Update of sections 4.4 and 4.8 of the SmPC concerning cases of anaphylaxis and/or anaphylactic shock with potential fatal outcome reported in the post-marketing setting. The Package Leaflet has been updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives for Italy and Latvia in the Package Leaflet. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance | 07/07/2016   | 24/05/2017 | SmPC and PL     | N/A                                 |

<div style=\"page-break-after: always\"></div>

| IB/0050   | - Change in test procedure for the finished - Other changes to a test procedure replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 14/06/2016   | n/a        |    | B.II.d.2.d product (including   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|---------------------------------|
| N/0048    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 14/07/2015   | 22/02/2016 | PL |                                 |
| IB/0047/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State | 28/05/2015   | n/a        |    |                                 |

<div style=\"page-break-after: always\"></div>

|           | variation                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                 |                                                                                                                                                                                                                                                 |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0046/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.z - Quality change - Active substance - Other variation                                                                                                  | 05/05/2015 | n/a        |                 |                                                                                                                                                                                                                                                 |
| II/0044   | Update of section 4.8 of the SmPC to list all ADRs in a single table and to reflect the results of the re- categorisation of the frequency for nausea, vomiting, headache, fever and diarrhea to 'very common' following a PRAC request in conclusion of PSUV/0041). The Package Leaflet is proposed to be updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 26/03/2015 | 22/02/2016 | SmPC and PL     | The Tabulated list of adverse reactions in section 4.8 of the SmPC has been updated to include all adverse reactions and to reflect that nausea, vomiting, headache, fever and diarrhea have been re-clasified to a frequency of \"very common\". |
| IAIN/0045 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                                                                        | 19/02/2015 | 22/02/2016 | Annex II and PL |                                                                                                                                                                                                                                                 |
| IB/0043/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or                                                                                                                                                                                                                                                                                                                                                 | 02/01/2015 | n/a        |                 |                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|           | starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure   |            |            |                 |                                                                                                                                                     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0041 | Periodic Safety Update                                                                                                                                                                                                                                                                              | 23/10/2014 | 16/12/2014 | SmPC and PL     | Please refer to Fasturtec PSUV 0041 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| IG/0454   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                     | 17/07/2014 | n/a        |                 |                                                                                                                                                     |
| N/0040    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                    | 29/04/2014 | 27/10/2014 | PL              |                                                                                                                                                     |
| IAIN/0039 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                      | 15/11/2013 | 27/10/2014 | SmPC and PL     |                                                                                                                                                     |
| IG/0313   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                      | 24/06/2013 | n/a        |                 |                                                                                                                                                     |
| IA/0037   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                 | 05/06/2013 | n/a        |                 |                                                                                                                                                     |
| IAIN/0036 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer responsible for                                                                                                                                                                                                 | 07/11/2012 | 20/11/2013 | Annex II and PL |                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|           | batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |            |                        |                                                                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------|
| II/0034   | Update of section 4.1 and 5.1 of the SmPC in order to clarify the age range of paediatric patients following CHMP request made further to the assessment of a study submitted in accordance with Article 46 of Regulation (EC) No1901/2006 (P46- 042). The Package leaflet is updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in the Package Leaflet. C.I.3.z - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Other | 20/09/2012 | 25/10/2012 | SmPC and PL            | Please refer to EPAR - Assessment Report Fasturtec-H-C- 331-II-0034. |
| II/0035   | Change to the manufacture of the finished product B.II.b.3.c - Change in the manufacturing process of the finished product - The product is a biological/immunological medicinal product and the change requires an assessment of comparability                                                                                                                                                                                                                                                                                                                                                                      | 20/09/2012 | n/a        |                        |                                                                      |
| T/0033    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 25/04/2012 | 25/05/2012 | SmPC, Labelling and PL |                                                                      |
| IAIN/0032 | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/03/2012 | 25/05/2012 | SmPC, Labelling and PL |                                                                      |

<div style=\"page-break-after: always\"></div>

| II/0031   | Update of SmPC section 5.2 based on pharmacokinetic data obtained from healthy adult subjects as well as adult patients. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                          | 16/02/2012   | 19/03/2012   | SmPC                             | The pharmacokinetics of rasburicase were evaluated in both paediatric and adult patients with leukemia, lymphoma or other haematological malignancies. Clearance of rasburicase was ca. 3.5 ml/h/kg. The mean terminal half-life was similar between paediatric and adult patients and ranged from 15.7 to 22.5 hours. In adults (≥ the age of 18 years), age, gender, baseline liver enzymes and creatinine clearance did not impact the pharmacokinetics of rasburicase. A cross-study comparison revealed that after administration of rasburicase at 0.15 or 0.20 mg/kg, the geometric mean values of body-weight normalized clearance were approximately 40% lower in Japanese (n=20) than that in Caucasians (n=26).                                                                                                                                                                                                                                                                                                                                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0030   | Update of SmPC sections 4.4 and 5.1 based on the results of a Phase 3 study in adult patients with hyperuricemia or at high risk for tumour lysis syndrome (EFC4978). The MAH also took the opportunity to introduce changes to the PI in line with QRD template version 8, revision 1 as well as an update of the List of local Representatives. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data | 16/02/2012   | 19/03/2012   | SmPC, Annex II, Labelling and PL | In a randomized (1:1:1), multi-center, open-label study, 275 adult patients with leukemia and lymphoma at risk for hyperuricemia and tumour lysis syndrome (TLS) were treated with either rasburicase at a dose of 0.2 mg/kg/day, intravenously, for 5 days (arm A: n=92), rasburicase at a dose of 0.2 mg/kg/day, intravenously, from day 1 through day 3 followed by oral allopurinol at a dose of 300 mg once a day from day 3 through day 5 (overlap on day 3: rasburicase and allopurinol administered approximately 12 hours apart) (arm B: n=92), or oral allopurinol at a dose of 300 mg once a day for 5 days (arm C: n=91). The uric acid response rate (proportion of patients with plasma uric acid levels ≤7.5 mg/dl from day 3 to day 7 after initiation of antihyperuricemic treatment) was 87% in arm A, 78% in arm B, and 66% in arm C. The response rate in arm A was significantly greater than in arm C (p=0.0009); the response rate was higher for arm B compared to arm C although this difference was not statistically significant. Uric |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                                                 |            |            |                        | acid levels were <2 mg/dl in 96% of patients in the two arms containing rasburicase and 5% of patients in the allopurinol arm at 4 hours of the day 1 dose. The safety results of patients treated with Fasturtec in Study EFC4978 were consistent with the adverse events profile observed in previous clinical studies with predominantly paediatric patients.   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0029  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                | 23/04/2009 | n/a        | Labelling and PL       |                                                                                                                                                                                                                                                                                                                                                                    |
| II/0028 | Update of SPC section 4.8 and PL section 4 with the adverse event \"urticaria\" as requested by the CHMP following the assessment of the PSUR 9-13. Update of Summary of Product Characteristics, Labelling and Package Leaflet                                                   | 22/01/2009 | 26/02/2009 | SmPC, Labelling and PL | With the assessment of the PSUR the CHMP noted that since all the safety information listed in the CCSI should be included in the SPC, the adverse event \"urticaria\" should be added to the sentence \"common allergic reactions, mainly rash and urticaria\". Consequently, the PL section 4 has also been amended.                                                 |
| II/0027 | Additional manufacturing and EU batch release site for the drug product with consequential changes to the manufacturing process and control of the drug product. Additional vial supplier for the drug product. Change(s) to the manufacturing process for the finished product | 18/12/2008 | 26/01/2009 | Annex II and PL        |                                                                                                                                                                                                                                                                                                                                                                    |
| II/0024 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                 | 24/01/2008 | 28/02/2008 | Annex II               |                                                                                                                                                                                                                                                                                                                                                                    |
| N/0026  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                | 11/02/2008 | n/a        | PL                     |                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

| II/0022   | Change(s) to the manufacturing process for the finished product                                                                                                                   | 18/10/2007   | 24/10/2007   |                 |                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0023   | Update of section 4.9 \"Overdose\" of the SPC in order to reflect the fact that cases of overdose have been reported with rasburicase. Update of Summary of Product Characteristics | 20/09/2007   | 19/10/2007   | SmPC            | To update further the source for the change proposed, the sentence \"No case of overdose has been reported\" has been deleted from section 4.9 of the SPC.                                                                                                                                                                                                                                                    |
| II/0021   | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                  | 21/06/2007   | 10/08/2007   | SmPC and PL     | The MAH has applied to modify sections 4.2 and 5.1 with additional paediatric data available. This variation was requested by the CHMP in June 2006 following assessments of the data submitted by the MAH in March 2006.                                                                                                                                                                                   |
| IA/0020   | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                                                | 01/03/2007   | n/a          | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0019   | Update of Summary of Product Characteristics                                                                                                                                      | 27/07/2006   | 01/09/2006   | SmPC            | The MAH has applied to update section 4.6 of the SPC in order to update non-clinical information.                                                                                                                                                                                                                                                                                                           |
| II/0018   | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                  | 28/06/2006   | 07/08/2006   | SmPC and PL     | The MAH has applied to update section 4.2 of the SPC to modify treatment duration. In addition, the MAH also takes this opportunity to include modifications in sections 3 and 6 of the Package Leaflet to update the list of Local Representatives and to update one sentence in the section \"information intended for healthcare professionals\" in order to bring it in line with section 6.6 of the SPC. |
| II/0017   | Change(s) to the manufacturing process for the active substance                                                                                                                   | 27/04/2006   | 05/05/2006   |                 |                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| II/0016   | Update of Summary of Product Characteristics and Package Leaflet                                   | 23/03/2006   | 27/04/2006   | SmPC and PL                      | The MAH has applied to update section 4.8 of the SPC and section 4 of the Package Leaflet, accordingly. This variation application is submitted following the assessment of 7th and 8th PSURs. The MAH has also taken the opportunity to update the list of local representatives in the Package Leaflet.   |
|-----------|----------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0015    | Renewal of the marketing authorisation.                                                            | 14/12/2005   | 09/02/2006   | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                                             |
| II/0012   | Change(s) to the manufacturing process for the active substance                                    | 27/07/2005   | 08/08/2005   |                                  |                                                                                                                                                                                                                                                                                                             |
| II/0011   | Change(s) to the test method(s) and/or specifications for the active substance                     | 27/07/2005   | 08/08/2005   |                                  |                                                                                                                                                                                                                                                                                                             |
| IA/0014   | IA_05_Change in the name and/or address of a manufacturer of the finished product                  | 03/08/2005   | n/a          |                                  |                                                                                                                                                                                                                                                                                                             |
| N/0013    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 12/07/2005   | n/a          | PL                               |                                                                                                                                                                                                                                                                                                             |
| IA/0010   | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.) | 29/03/2005   | n/a          | Annex II                         |                                                                                                                                                                                                                                                                                                             |
| IA/0009   | IA_01_Change in the name and/or address of the marketing authorisation holder                      | 10/12/2004   | n/a          | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                             |
| IA/0008   | IA_05_Change in the name and/or address of a manufacturer of the finished product                  | 10/12/2004   | n/a          | Annex II and PL                  |                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| IB/0007   | IB_37_a_Change in the specification of the finished product - tightening of specification limits   | 11/11/2004   | n/a        |                        |
|-----------|----------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| N/0006    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 31/08/2004   | n/a        | PL                     |
| IB/0005   | IB_37_a_Change in the specification of the finished product - tightening of specification limits   | 24/06/2004   | n/a        |                        |
| I/0004    | 17_Change in specification of the medicinal product                                                | 10/10/2003   | 16/10/2003 |                        |
| II/0002   | Update of Summary of Product Characteristics and Package Leaflet                                   | 19/03/2003   | 30/06/2003 | SmPC and PL            |
| I/0003    | 20_Extension of shelf-life as foreseen at time of authorisation                                    | 18/04/2003   | 04/06/2003 | SmPC                   |
| II/0001   | New presentation(s)                                                                                | 17/01/2002   | 18/04/2002 | SmPC, Labelling and PL |